New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis

Cytokine and Growth Factor Reviews

Volumn 14, Issue 5, 2003, Pages 369-374

  Micera, Alessandra ^a   Puxeddu, Ilaria ^a   Aloe, Luigi ^b   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CNR   (Italy)

Author keywords

Allergy; Eosinophils; Fibrosis; Inflammation; Mast cells; Myofibroblasts; NGF

Indexed keywords

NERVE GROWTH FACTOR;

ALLERGY; EOSINOPHIL; FIBROSIS; IMMUNE SYSTEM; INFLAMMATION; MAST CELL; MYOFIBROBLAST; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; PRIORITY JOURNAL; SHORT SURVEY; TISSUE REPAIR; ULCER;

EID: 0042375985     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00047-9     Document Type: Short Survey

References (65)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
2. Barde YA. The nerve growth factor family. Prog Growth Factor Res 1990;2:237-48.
3. Dracopoli NC, Meisler MH. Mapping the human amylase gene cluster on the proximal short arm of chromosome 1 using a highly informative (CA)n repeat. Genomics 1990;7:97-102.
4. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997;52:883-94.
5. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992;15:323-31.
6. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991;350:678-83.
7. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217-81.
8. Esposito D, Patel P, Stephens RM, et al. The cytoplasmic and transmembrane domains of the p75 and trkA receptors regulate high affinity binding to nerve growth factor. J Biol Chem 2001;276:32687-95.
9. Wooten MW, Seibenhener ML, Mamidipudi V, et al. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kB activation by nerve growth factor. J Biol Chem 2001;276:7709-12.
10. Culmsee C, Gerling N, Lehmann M, et al. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75. Neuroscience 2002;115:1089-108.
11. Aloe L, Micera A, Bonini Se. Nerve growth factor, mast cells, and allergic inflammation. In: Marone G, Lichtenstein LM, Galli SJ, editors. Mast cells and basophils. New York: Academic Press; 2000;325-39.
12. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
13. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature, human basophils. Blood 1992;79:2662-9.
14. Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997;100:408-14.
15. Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B-lymphocytes. Cell 1996;85:345-56.
16. Torii H, Yan Z, Hosoi J, Granstein RD. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cell-like cell line XS52: further support for a functional relationship between mangerhans cells and epidermal nerves. J Invest Dermatol 1997;109:586-91.
17. Solomon A, Aloe L, Pe'er J, et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998;102:454-60.
18. Aloe L, Tuveri MA. Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheum 1997;15:433-8.
19. Bonini S, Lambiase A, Bonini S, Levi-Schaffer F, Aloe L. Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int Arch Allergy Immunol 1999;118:159-62.
20. Holgate ST, Church MK, Lichtenstein LM. Allergy. 2nd ed. London: Mosby International; 2001.
21. Galli SJ, Williams CMM. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000;105:847-59.
22. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev 2000;173:131-40.
23. Smith S, Levi-Schaffer F. Cross-talk between eosinophils, mast cells and fibroblasts. Chem Immunol 2000;78:81-92.
24. Gleich GJ, Ottesen EA, Leiferman KM, Ackerman SJ. Eosinophils and human disease. Int Arch Allergy Appl Immunol 1989;88:59-62.
25. Levi-Schaffer F, Garbuzenko E, Rubin A, et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor β (TGF-β). Proc Natl Acad Sci USA 1999;96:9660-5.
26. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. Mast cells enhance eosinophil survival in vitro: role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol 1998;60:5554-62.
27. Temkin V, Levi-Schaffer F. Mechanism of tumor necrosis factor alpha mediated eosinophil survival. Cytokine 2001;15:20-6.
28. Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 2001;107:993-1000.
29. Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003;101:1898-904.
30. Matsuda H, Kannan Y, Ishio H, et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991;174:7-14.
31. Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM. Nerve growth factor-β induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000;99:418-26.
32. Welker P, Grabbe J, Grutzkau A, Henz BM. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998;94:310-7.
33. Horigome K, Bullock ED, Johnson Jr EM. Effect of nerve growth factor or rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 1994;269:2695-702.
34. Tam SY, Tsai M, Yamaguchi M, et al. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997;90:1807-20.
35. Nilson G, Forsberg-Nilson K, Xiang Z, Hallbook F, Nilson K, Metcalf DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997;27:2295-301.
36. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-66.
37. Aloe L. The effects of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol 1988;18:1-12.
38. Lambiase A, Bonini S, Bonini S, Micera A, Magrini L, Bracci-Laudiero L, et al. Increased plasma levels of nerve growth factor in Vernal Keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci 1995;36:2127-32.
39. Bonini S, Lambiase A, Bonini S, et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-60.
40. Sanico AM, Stanisz AM, Gleeson TD, et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000;161:1631-5.
41. Kassel O, De Blay F, Duvernelle D, et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001;31:1432-40.
42. Renz H. The role of neurotrophins in bronchial asthma. Eur J Pharmacol 2001;429:231-7.
43. De Vries A, Dessing MC, Engels F, Henricks PAJ, Nijkamp FP. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999;159:1541-4.
44. De Vries A, Engels F, Henricks PAJ, Leusnk-Muis T, Fischer A, Nijkamp FP. Antibodies directed against nerve growth factor inhibit the acute bronhocostriction due to allergen challenge in guinea pig. Clin Exp Allergy 2002;32:325-8.
45. Olgart C, De Blay F, Oster JP, et al. Nerve growth factor levels and localization in human asthmatic bronchi. Eur Respir J 2002;20:1110-6.
46. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002;99:2214-20.
47. Zamir E, Mechoulam H, Micera A, Levi-Schaffer F. Pe'er J. Inflamed juvenile conjunctival naevus: clinicopathological characterisation. Br J Ophthalmol 2002;86:28-30.
48. Levi-Schaffer F, Micera A, Zamir E, et al. Nerve growth factor and eosinophils in Inflamed Juvenile Conjunctival Nevus: a link with allergy. Invest Ophthalmol Vis Sci 2002;43:1850-6.
49. Levi-Schaffer F, Micera A, Maquart FX, Aloe L. Nerve growth factor is produced by human fibroblasts and modulates them: role of nerve growth factor in tissue repair. Int Arch Allergy Immunol 2001;124:279-81.
50. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002;3:349-63.
51. Solomon A, Shmilowich R, Sheasha D, et al. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Ophthalmol Vis Sci 2000;41:1038-44.
52. Garbuzenko E, Nagler A, Pickholz D, et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy 2002;32:237-46.
53. Lawrence DA. Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996;7:363-74.
54. Kasemkijwattana C, Menetrey J, Somogyl G, et al. Development of approaches to improve the healing following muscle contusion. Cell Transplant 1998;7:585-98.
55. Matsuda H, Koyama H, Sato H, et al. Role of nerve growth factor in cutaneous wound-healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998;187:297-306.
56. Bernabei R, Landi F, Bonini S, et al. Effect of topical application of nerve growth factor on pressure ulcers. Lancet 1999;354:307-8.
57. Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000;356:1739-40.
58. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. New Engl J Med 1999;338:1174-80.
59. Lambiase A, Bonini S, Aloe L, Rama P, Bonini S. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 2000;118:1446-8.
60. Friess H, Zhu ZW, di Mola F, et al. Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999;230:615-24.
61. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-7.
62. Koyama T, Liu X, Wen FQ, et al. Nerve growth factor stimulates fibronectin-induced fibroblast migration. J Lab Clin Med 2002;140:329-35.
63. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383:716-9.
64. Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenic and vasoactive factors. Proc Natl Acad Sci USA 2001;98:4160-5.
65. Cantarella G, Lempereur L, Presta M, et al. Nerve growth factor-endothelial cell interaction leads to Angiogenesis in vitro and in vivo. FASEB J 2002;16:1307-9.